. 2023 Aug 17;11(8):2287. doi: 10.3390/biomedicines11082287
© 2023 by the authors.
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Figure 6.
Slide 16 FDA’s VRBPAC meeting, Oct. 2022 [99].